How Long Can You Stay on HRT?

There is no five-year limit on hormone therapy and no age at which it must stop. That rule came from the way the 2002 Women’s Health Initiative results were reported, and it was never a guideline. The Menopause Society and ACOG say duration is individual and should be reviewed each year against whether symptoms persist, your risks at your current age and your goals. Some women take hormone therapy for two years; some for twenty. After 60, and with more years on treatment, the balance of benefit and risk changes.

What the guidelines actually say

Three points, from The Menopause Society’s 2022 position statement and ACOG’s guidance:

1. No arbitrary stopping point. Neither a number of years nor an age. The decision to continue is a yearly review of benefits and risks, not a countdown.
2. The best time to start is early. Within ten years of menopause or before 60, which is what the FDA’s updated labelling also recommends. Starting early and continuing is a different risk picture from starting late.
3. Continuing past 60 or 65 can be reasonable when symptoms persist, quality of life depends on it, or bone protection is needed and alternatives don’t suit, with shared decision-making, the lowest effective dose and usually a transdermal form.

If your prescriber has told you to stop because you’ve “been on it long enough”, ask what has changed in your risk profile.

The yearly review

Each year, with your prescriber, four questions:

• Do you still need it? The honest test is a trial reduction. If symptoms return, you still need it; if they don’t, you may be ready to taper.
• What has changed in your risks? A new diagnosis, a blood pressure drift, a family history update, a clot in a relative, a change in weight or smoking.
• Is it the right form and dose? Age pushes toward transdermal and toward the lowest dose that holds symptoms; see HRT dose adjustments and patch vs pill vs gel.
• Is the screening up to date? Mammography on schedule, blood pressure checked, any bleeding investigated. Bleeding after a settled pattern, at any point on treatment, needs evaluation; see bleeding after menopause.

What changes after 60

Age raises the baseline risk of clots, stroke and breast cancer for every woman, on hormones or not, so the same treatment carries a slightly larger absolute risk at 65 than at 52. That doesn’t make it wrong; it changes the conversation:

• Starting fresh after 60 or more than ten years past menopause is a specialist decision, because the cardiovascular evidence is less favourable for late starters. Local vaginal estrogen is fine to start at any age.
• Continuing after 60 for persistent hot flashes is reasonable. About a quarter of women still have flashes well into their sixties, and “wait it out” is poor advice when the wait is a decade.
• The form matters more. Transdermal estradiol, which doesn’t raise clotting factors, and micronised progesterone, which carries less breast risk than older progestins, become the default.
• Bone becomes a bigger part of the decision. Hormone therapy prevents the bone loss that accelerates after menopause; for a woman with osteopenia who can’t tolerate bone medications, that can be the reason to continue.

Hormone therapy is not FDA-approved to prevent heart disease or dementia, at any age, and it shouldn’t be continued for those reasons.

What accumulates with time, and what doesn’t

	Changes with duration?	Notes
Breast cancer	Yes, small, with some combined regimens beyond about five years	Less with estrogen alone (after hysterectomy) and with micronised progesterone; the absolute increase is small and comparable to other lifestyle factors
Blood clots and stroke	Tied to age and route more than duration	Lower with transdermal; this is why forms are revisited with age
Endometrial cancer	Not if a progestogen is used correctly	Why the progestogen can’t be skipped with a uterus
Gallbladder disease	Slightly higher with oral estrogen	Transdermal avoids it
Bone protection	Benefit continues while on treatment, fades after stopping	A reason some women continue
Hot flashes, sleep, mood, dryness	Benefit continues; symptoms often return when stopped	About half of women have flashes return

The BHRT guide covers the safety evidence and the FDA’s 2025 labelling change in more detail.

If you want to stop

If you’ve decided to stop, these are the usual steps:

1. Pick a quiet time. Not mid-winter if sweats were your issue, not during a stressful stretch.
2. Taper over three to six months. Trials find similar recurrence whether you stop abruptly or taper, but a taper is more comfortable and lets you see whether symptoms are returning at each step. Patches step down in strength; gel by the pump; pills by dose or alternate days under guidance. The progestogen stops when the estrogen does.
3. Expect some return. Around half of women get hot flashes back, which may be milder than before. Sleep and mood can wobble for a few weeks as levels settle.
4. Keep the local estrogen. Vaginal and bladder symptoms return when vaginal estrogen stops, and there’s no reason to stop it; see vaginal dryness.
5. Have a plan for the symptoms. CBT, the sleep rules, and the non-hormonal prescriptions in who should not take HRT all work after stopping as well as instead of starting.

If symptoms return and life is worse, restarting is reasonable. This is not dependence; it is the return of the symptoms the hormones were treating.

Early and premature menopause: a different rule

If menopause came before 45, and especially before 40, hormone therapy is replacement rather than treatment: it supplies what the body would have made until the usual age. Guidelines advise continuing at least until the average age of menopause, around 51, for bone, heart and brain health, and then making the ordinary yearly decision from there. See when menopause starts.

How this works at Golden Leaf Health

Duration is part of every yearly review with your clinician: what’s still needed, what’s changed, whether the form and dose still fit your age and risks, and your goals. If you’ve been told to stop elsewhere without a reason, bring that question here. Book a first visit if you’d like a second opinion on staying, adjusting or stopping.

Sources: The Menopause Society, 2022 hormone therapy position statement; ACOG, Hormone therapy for menopause; National Institute on Aging, Hormone therapy; Mayo Clinic, Hormone therapy: is it right for you?.